PLoS ONE (Jan 2015)

Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks.

  • Frederick A Sirgel,
  • Robin M Warren,
  • Erik C Böttger,
  • Marisa Klopper,
  • Thomas C Victor,
  • Paul D van Helden

DOI
https://doi.org/10.1371/journal.pone.0134190
Journal volume & issue
Vol. 10, no. 7
p. e0134190

Abstract

Read online

No abstracts available.